We blogged and posted on our Facebook page yesterday about the FDA’s approval of Allergan’s Juvederm Voluma XC – one of the most highly anticipated non-surgical treatment options for age related volume loss in the midface/cheek area.  What’s different about Voluma?  It is the first FDA approved injectable filler product specifically formulated to fill the cheeks and midface. Board Certified Plastic Surgeon Brian S. Glatt, MD, FACS will be one of the first 200 physicians in the nation to receive Juvederm Voluma XC for his patients.  The latest information about Juvederm Voluma XC, including product arrival date, which we expect to be within the month, will be posted here in our blog and  on our Facebook page.  We at Premier Plastic Surgery Center of New Jersey are very excited about this new product and want to “fill you in” (pun intended).

  • As people age, the midface area can lose volume, causing the cheeks to flatten out and the skin to droop and sag.   Juvederm Voluma XC is a gel that is injected into the cheek area to gently lift the sagging skin, producing a natural, more youthful appearance.
  • Juvederm Voluma XC is a modified form of hyalouronic acid, a natural complex sugar that occurs within the body.
  • Juvederm Voluma XC is made with a proprietary technology, VYCROSS, which results in a smooth gel and contributes to the lift capacity and the duration of the product.  The product also contains a small amount of lidocaine  to help numb the treatment area.
  • The results of Juvederm Voluma XC are long-lasting – up to two years.

If you have any questions about Juvederm Voluma XC or any other injectable fillers please contact our Morristown office at 973-889-9300.



  • Share: